Videos de Experimentos Relacionados
Estudio de protección cardíaca Estudio de protección cardíaca.
Lancet (London, England)
|February 14, 2003
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
LDL-cholesterol distance to target: A practical tool for guiding lipid-lowering treatment decisions.
Atherosclerosis plus·2026
Same author
The year in Cardiovascular Medicine 2025: the top 10 papers in dyslipidaemias.
European heart journal·2026
Same author
Definition of maximum daily amounts of vitamins and minerals allowed in food supplements: scientific rationale and European regulatory frameworks.
Archives of medical science : AMS·2025
Same author
Interpreting substitution models in nutritional epidemiology: the case for the protective role of NOVA 1 foods over the risk of NOVA 4.
The Lancet. Planetary health·2025
Same author
Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA).
Nutrition, metabolism, and cardiovascular diseases : NMCD·2025
Same author
Physician and patient perspectives on the treatment of hypercholesterolaemia: a cross-sectional study to identify disconnects.
Current medical research and opinion·2025
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026